The Caenorhabditis elegans defecation motor program (DMP) is a highly coordinated rhythmic behavior that requires two GABAergic neurons that synapse onto the enteric muscles. One class of DMP mutants, called anterior body wall muscle contraction and expulsion defective (aex) mutants, exhibits similar defects to those caused by the loss of these two neurons. Here, we demonstrate that aex-2 encodes a G-protein-coupled receptor (GPCR) and aex-4 encodes an exocytic SNAP25 homologue. We found that aex-2 functions in the nervous system and activates a Gs␣ signaling pathway to regulate defecation. aex-4, on the other hand, functions in the intestinal epithelial cells. Furthermore, we show that aex-5, which encodes a pro-protein convertase, functions in the intestine to regulate the DMP and that its secretion from the intestine is impaired in aex-4 mutants. Activation of the Gs␣ GPCR pathway in GABAergic neurons can suppress the defecation defect of the intestinal mutants aex-4 and aex-5. Lastly, we demonstrate that activation of GABAergic neurons using the light-gated cation channel channelrhodopsin-2 is sufficient to suppress the behavioral defects of aex-2, aex-4, and aex-5. These results genetically place intestinal genes aex-4 and aex-5 upstream of GABAergic GPCR signaling. We propose a model whereby the intestinal genes aex-4 and aex-5 control the DMP by regulating the secretion of a signal, which activates the neuronal receptor aex-2.
he Caenorhabditis elegans defecation motor program (DMP) is a highly coordinated series of three muscle contractions that are executed every 45 sec [ Fig. 1A and supporting information (SI) Movie S1]. The cycle is initiated by a posterior body wall muscle contraction (pBoc), followed 2-3 sec later by an anterior body wall muscle contraction (aBoc). About 1 sec after the aBoc, enteric muscles contract, thus causing the expulsion (Exp) of intestinal contents. The process repeats itself Ϸ45 sec later with little variability in the timing of contractions (1) . A genetic screen for mutants that displayed defects in the DMP isolated mutants defective in each of the three muscle contractions, known as pbo, abo, and exp (1) . The screen also recovered mutants defective in the last two muscle contractions (aBoc and Exp [aex] ) and mutants defective in the cycle periodicity (i.e., longer or shorter than normal DMP cycling times) (1) . Molecular studies of these mutants have suggested that the behavior is orchestrated through the communication between the intestine, GABAergic neurons, and muscle.
The periodicity of the DMP is regulated by the C. elegans intestine, a single-cell layer tube of polarized epithelial cells joined by gap junctions (2, 3) . Intestinal Ca 2ϩ oscillations with Ϸ45-sec periodicity appear to play a central role in this timing. They consist of a posterior-to-anterior Ca 2ϩ wave whose levels peak in the posterior and anterior intestinal cells just before the pBoc and aBoc contractions, respectively (3) (4) (5) . Mutations in genes involved in the maintenance of Ca 2ϩ oscillations or in the propagation of Ca 2ϩ waves between cells affect the periodicity of the DMP (3) (4) (5) . These studies suggest that the intestine may control the timing of the DMP via a Ca 2ϩ -dependent process, such as Ca 2ϩ -induced exocytosis. Furthermore, recent work demonstrates that the intestine induces the pBoc by releasing protons (through a Na ϩ /H ϩ exchanger) onto posterior body wall muscle cells (6) . The posterior body wall muscle cells contract in response to the change in pH because they express a proton-gated cation channel (6) . By contrast, the Exp step of the DMP is regulated by the GABAergic neurons AVL and DVB (7, 8) . These neurons secrete GABA onto enteric muscles that express the excitatory GABA receptor EXP-1 and cause them to contract (9) . If the intestine is the cycle timer and initiates the pBoc step and neurons initiate the Exp step, then how are the intestinal-and neuronal-mediated behaviors synchronized? It seems likely that studies of aex genes will give some insight into how the AVL and DVB neurons are activated, because the behavioral defects of aex mutants are reminiscent of animals whose AVL and DVB GABAergic neurons are laser ablated (7, 8) . aex-3 and aex-6 regulate synaptic transmission, probably by regulating exocytosis of neurotransmitter: aex-3 is a guanine nucleotide exchange factor that regulates Rab small guanosine triphosphatase function, and aex-6 (also known as rab-27) is a Rab small guanosine triphosphatase that regulates secretory vesicle exocytosis (10, 11) . aex-5 encodes a pro-protein convertase, an enzyme that is copackaged with propeptides and processes them to make mature secretory molecules (12, 13) . Lastly, Doi and Iwasaki (12) demonstrated that aex-1 is a distant homologue of the synaptic gene unc-13 (or Munc13), which acts in the intestine to regulate the DMP. Thus, prior molecular characterization of aex genes implicates that a secretory event is in control of aBoc and Exp.
Here, we uncover how the intestinal cells regulate the activity of GABAergic neuronal function during the DMP. We cloned aex-4, which encodes a SNAP25 soluble N-ethylmaleimide sensitive factor attachment receptor (SNARE) homologue, and aex-2, which encodes a G-protein-coupled receptor (GPCR). We demonstrate that whereas aex-4 and aex-5 act in the intestine to regulate defecation, aex-2 functions in GABAergic neurons to control this behavior. Disruption of aex-4 function blocks AEX-5 secretion from the intestine. Moreover, GABAergic expression of activated adenylyl cyclase or photoactivatable channelrho-dopsin (ChR2) rescues the defecation defects of aex-2, aex-4, and aex-5. We propose a model in which intestinal aex genes, aex-4 and aex-5, regulate secretion of a signal that activates the GPCR aex-2 in AVL and DVB, which, in turn, activates these neurons to complete the DMP.
Results aex Mutants Are Primarily Defective in Exp and Only Mildly Defective in aBoc.
To understand better how the DMP operates, we carefully characterized the defecation defects of each of the aex mutants. aex mutants are primarily defective in the Exp step (Figs. S1 and S2) . Surprisingly, aex mutants have only slightly fewer aBoc contractions per defecation cycle than WT; however, those aBoc contractions are usually significantly later in the cycle than in a WT DMP (Figs. S1 and S2). Therefore, the aBoc defects of most aex mutants are relatively mild when compared with the Exp defects. Most aex mutants have a relatively normal cycle length (or period), although aex-5 did exhibit a slightly longer defecation cycle period (Fig. S1 ). The normal cycle periodicity suggests that these mutants do not have a defect in cycle time generation. Taken together, these results suggest that aex mutants are primarily defective in the Exp step.
aex-4 Encodes a SNARE Protein. We predicted that aex-4 would encode a protein involved in exocytosis, neuropeptide production, or neuropeptide signaling, because all other aex strains have mutations in genes regulating these pathways (10, 12, 14) . By searching the genomic interval in which aex-4 had been mapped (1), we identified a candidate gene for the aex-4 locus. All aex-4 alleles sequenced have mutations in the gene T14G12.2, and a 4-kb genomic clone of this gene is sufficient to rescue the defecation defect of aex-4 ( Fig. S3 and S4 A; SI Text, section V.B). Table S1 describes all transgenic strains used in this work. T14G12.2 encodes a homologue of the SNARE protein SNAP25 (Fig. S3) (15, 16) . These findings implicate aex-4 in exocytosis. AEX-4 Regulates the DMP from the Intestine. To dissect how AEX-4 regulates defecation behavior, we first determined the expression pattern of aex-4 by building a transgenic animal that expresses GFP fused to a nuclear localization signal under the aex-4 promoter (SI Text, section V.1). Surprisingly, aex-4 expresses only in intestinal cells (Fig. 1B) . To determine the subcellular localization of AEX-4, we built a transgene expressing a functional GFP-tagged AEX-4 fusion under its native promoter (SI Text, section V.C). GFP-tagged AEX-4 localizes along the plasma membrane of intestinal cells ( Fig. 1 C and D) . Therefore, AEX-4 likely acts at the surface of intestinal cells to regulate the DMP. We expressed the aex-4 gene under an intestinal-specific promoter, a muscle-specific promoter, and a neuronal-specific promoter to determine in what tissue aex-4 regulates the DMP (SI Text, section V.D-F). Intestinal expression of aex-4 fully rescues the defecation defects of aex-4 mutant animals ( Fig. 2A and Fig. S4 B and C), whereas muscle-and neuronal-specific promoters only partially rescue the defecation defect of aex-4 mutants (Fig. 2 A) .
To verify our tissue-specific rescue experiments, we tested whether RNAi of aex-4 in a strain that is only sensitive to RNAi in the intestine would result in a defecation defect (17) . Indeed, intestinal-specific RNAi of aex-4 results in a strong Exp defect consistent with aex-4 functioning in the intestine (Fig. 2C ). In addition to aex-4, RNAi of aex-5 and aex-6 in the intestinalspecific RNAi strain causes a strong Exp defect. RNAi of aex-3 causes a moderate Exp defect similar to that of the aex-3 loss of function (Fig. S1 ). These results are consistent with aex-3, aex-4, aex-5, and aex-6 functioning in the intestine. RNAi of aex-1, in contrast, causes only a mild defect in Exp, although tissuespecific rescue experiments suggest that aex-1 functions in the intestine (12) . We suspect that aex-1 levels were not reduced enough in the intestinal-specific RNAi strain, because RNAi of aex-1 in WT strains causes a strong Exp defect (data not shown). Combined together, these results strongly suggest that a cohort of exocytic aex genes, including aex-4, all function in the intestine to regulate the DMP.
AEX-5
Regulates the DMP from the Intestine. aex-5 encodes a pro-protein convertase and was identified in the same screen that isolated aex-4 (1, 12, 13) . We confirmed that the pro-protein convertase gene is mutated in aex-5(sa23) by sequencing (lesion is C443W) and by genomic fosmid rescue (Fig. S4A) . Because aex-4 likely regulates secretion of a signal from the intestine and pro-protein convertases are typically packaged into secretory vesicles (14) , we wished to determine whether AEX-5 is secreted from the intestine. A transgene in which intestinal-specific expression of AEX-5, fused to the VENUS variant of GFP (18), was driven fully rescues the defecation defects of aex-5 mutant animals, whereas muscle-and neuronal-specific expression only partially rescues the defecation defects (Fig. 2 A; Fig. S4 B and C; and SI Text, section V.G-I). AEX-5::VENUS is secreted from the intestine and subsequently endocytosed by coelomocytes, specialized endocytic cells in C. elegans ( Fig. 1 E-F) . These findings suggest AEX-5 is secreted from the intestine, where it regulates the DMP. aex-2 Encodes a GPCR. We mapped aex-2 to a region on the X chromosome and revealed that the gene T14B1.2 encodes aex-2. All sequenced aex-2 alleles have mutations in T14B1.2, and a transgene that contains the T14B1.2 gene rescues the aex-2 mutant phenotype (SI Text, section V.10-11 and Figs. S4A and S6). T14B1.2 encodes a protein that shares homology with the A class of GPCRs, some of which mediate peptide signaling (Fig.  S6) (19) . When expressing an mCherry-tagged aex-2 genomic fusion construct (which fully rescues the aex-2 defecation de- fects), we detected AEX-2::mCherry signal in the nerve ring, ventral nerve cord, and enteric muscles ( Fig. 1 G-I ; SI Text, section V.J-K). So, unlike aex-4, which is exclusively expressed in the intestine, aex-2 is expressed in neuronal and nonneuronal tissues. Although neuronal expression of AEX-2::GFP fully rescues the defecation defects of aex-2 mutants, muscular and intestinal aex-2 does not (Fig. 2 A) . Consistent with this observation, intestinal-specific RNAi of aex-2 does not cause a robust defecation defect (Fig. 2C) . Thus, unlike aex-4 and aex-5, aex-2 acts in neurons to regulate the DMP.
Because previous studies have indicated that the GABAergic neurons AVL and DVB are required for Exp (7), we analyzed the expression pattern of our aex-2 in various neuronal subtypes. We coexpressed mCherry protein under the aex-2 promoter with the GFP under a unc-17 (drives expression in cholinergic neurons), a glr-1 (drives expression in subsets of interneurons), or a unc-47 (drives expression in GABAergic neurons) promoter to assess if any of the aex-2-positive neurons are colabeled by these neuronal subtype-specific markers (SI Text, section V.O). We found that the aex-2 reporter is detected in all three neuronal cell types ( Fig. 1 J-L and Fig. S7) . Briefly, at least one glutamatergic interneuron (likely AVD), several head and pharyngeal cholinergic neurons, and two GABAergic neurons (AVL and DVB) express mCherry under the control of the aex-2 promoter (Fig.  1 J-L and Fig. S7) . None of the ventral nerve cord motor neurons (neither cholinergic nor GA BAergic) are labeled by Paex-2::mCherry. Therefore, aex-2 is expressed in the defecation regulating GABAergic neurons (AVL and DVB) as well as in other types of nonmotor neurons.
To determine which neuronal subtype aex-2 functions in, we expressed an aex-2::GFP cDNA fusion under neuronal subtypespecific promoters. GABAergic expression of aex-2 significantly rescues the Exp defect and partially rescues the aBoc defect of aex-2 mutants, whereas the other two promoters do not (Fig. 2B and Fig. S4 B and C and SI Text, section V.P-R). Taken together, these results suggest that aex-2 acts in GABAergic neurons (i.e., AVL and DVB) to control the Exp, and perhaps the aBoc.
aex-2 Functions Through a Gs␣ Signaling Pathway.
Because aex-2 encodes a GPCR, we examined which G␣ subunit might act downstream of the aex-2 receptor signaling. To determine this, we genetically tested a variety of candidate G␣ subunits for their ability to suppress aex-2 mutant phenotype. We built double mutants between an aex-2 loss-of-function mutant and a gsa-1 (G s ␣) gain-of-function mutant (20) and an egl-30 (G q ␣) gainof-function mutant (21) (22) (23) . We also built an aex-2 and dgk-1 (which encodes a diacylglycerol kinase) double loss-of-function mutant, because dgk-1 normally antagonizes egl-30 signaling and its loss-of-function phenocopies egl-30 gain of function (21-23). G s ␣ gain-of-function mutation causes ectopic Exp in WT and aex-2 mutant animals, and it suppresses the Exp defect in aex-2 mutants (Fig. 4A) . On the other hand, the G q ␣ pathway mutants do not have a strong effect on the aex-2 phenotype (Fig. 4A) . Interestingly, gain of function in gsa-1 does not rescue the aBoc defect ( Fig. S4 B and C) . The irregular timing of Exps in gsa-1 mutants (i.e., some Exps do not occur at the proper time, which is 3 sec after pBoc) may account for the lack of rescue of aBoc in aex-2 mutants. To assess if the G s ␣ rescue is specifically mediated by GABAergic neurons, we tested whether the GABAergic expression of a gain-of-function adenylyl cyclase (acy-1) (24), a downstream effector of G s ␣, would suppress the defecation defects in aex-2 mutants (SI Text, section V.S). Similar to the gsa-1 gain-of-function mutant, overexpression of a gain-of-function acy-1 gene in aex-2 mutants causes ectopic Exps, and this expression significantly rescues the Exp defects in aex-2 mutants (Fig. 4A) . Taken together, these results support a model in which the aex-2 GPCR acts in GABAergic neurons to regulate the DMP via a downstream G s ␣ and adenylyl cyclase pathway.
GABAergic Neurons Act Downstream of AEX-4 and AEX-5 to Control
Defecation. Although aex-2 acts in AVL and DVB GABAergic neurons, aex-4 and aex-5 function in the intestine to regulate Exp. We wished to determine if aex-2 signaling acts downstream of intestinal aex-4 and aex-5. Because we have not identified the ligand for AEX-2, we asked whether gain-of-function mutations in the aex-2 pathway could suppress the aex-4 and aex-5 Exp defects. GABAergic expression of the gain-of-function acy-1 gene is sufficient to rescue the Exp defects seen in aex-4 and aex-5 mutants (Fig. 4A) . As seen in aex-2 mutants, overexpression of gain-of-function acy-1 in aex-4 and aex-5 mutants also causes ectopic Exps. These data suggest that GABAergic signaling of aex-2 acts downstream of intestinal signaling of aex-4 and aex-5. We wished to demonstrate that the role of aex-2, aex-4, and aex-5 is specifically to activate GABAergic neurons controlling the Exp step. We used YFP-tagged ChR2 under a GABAergic promoter to bypass the loss of these aex genes (SI Text, section VI). ChR2, from the green alga Chlamydomonas reinhardtii, is a light-activatable nonselective cation channel that, in the presence of all-trans-retinal, will depolarize excitable cells (25) . We hypothesized that the activation of GABAergic neurons using the ChR2 transgene would suppress the behavioral defect of each of the aex mutants. Indeed, activation of ChR2 in GABAergic neurons by brief (Ϸ1 sec) pulses of blue light Ϸ2 sec after pBoc is sufficient to rescue the Exp defects of aex-2, aex-4, and aex-5 mutants completely (Fig. 4B and Movie S2). These results strongly suggest that aex-2, aex-4, and aex-5 regulate the activity of GABAergic neurons AVL and DVB to induce Exp during the DMP.
Discussion
Several lines of evidence suggest that a group of exocytic genes function in the C. elegans intestine to control secretion of a signal to regulate the aBoc and Exp steps of the DMP. aex-1, aex-3,  aex-4 , and aex-6 are each homologous to the genes that regulate exocytosis in secretory cells (11, 12) . Here, we present data that these genes regulate the secretion of a signal from the intestine to induce aBoc and Exp. This model is further supported by the observation that aex-4 mutants prevent the secretion of an intestinal AEX-5::VENUS into the pseudocoelom and its subsequent endocytosis by coelomocytes. Therefore, aex-4 (and likely aex-1, aex-3, and aex-6) regulates the secretion of AEX-5 and, arguably, its substrate from the intestine. Although our data indicate aex-3 and aex-6 function in intestine, they do not exclude the possibility that these genes also function in AVL and DVB to regulate the DMP (see Fig. S8 for model) .
The model of the intestine secreting a signal to regulate Exp prompted us to search for the receptor for the signal. aex-2 encodes a putative GPCR, and our data suggest that this receptor likely functions in AVL and DVB GABAergic neurons to regulate Exp. Interestingly, when using a gain-of-function G s ␣ or an activated adenylyl cyclase that is expressed in GABAergic neurons, we suppressed the Exp defect not only in aex-2 but in the intestinal aex-4 and aex-5 mutants. These results are consistent with aex-2 encoding the receptor of the intestinal signal and acting downstream of intestinal aex genes.
We speculate that G s ␣ and adenylyl cyclase act downstream of aex-2 to excite AVL and DVB during the Exp. In support of this model, some gsa-1 loss-of-function animals, with a mosaic rescuing transgene, were reported to exhibit a defecation defect (26) . We also observed a robust defect in the Exp step in these animals (11% Ϯ 3%, P Ͻ 0.0005). In contrast, acy-1 loss-offunction mutants, with a rescuing transgene expressing in muscle (27) , do not have a significant defect in the Exp step (81% Ϯ 7%, P Ͼ 0.05). This may be attributable to redundancy of the three other adenylyl cyclase genes in C. elegans (28) and/or the action of other gsa-1 effectors acting in parallel to acy-1.
Activation of ChR2 in GABAergic neurons is sufficient to suppress the Exp defects of aex-2, aex-4, and aex-5 mutants. The aBoc defect of these aex mutants, however, was not rescued. Activation of GABAergic ChR2 causes the worm to become paralyzed as a result of muscle relaxation; therefore, it may be difficult to observe the aBoc contractions under these conditions. These findings indicate that the aex genes likely act to activate AVL and DVB GABAergic neurons through aex-2.
Although aex-2 is likely involved in AVL and DVB activation, it remains unclear how aex-2 is activated. Because aex-5 encodes a pro-protein convertase and aex-5 mutants are defective in neuropeptide production (13), we suspect that aex-2 encodes a neuropeptide-like receptor. There are Ϸ100 genes in the C. elegans genome encoding more than 250 peptides (29, 30) , many of which are expressed in the intestine. The identification of aex-2 ligand(s) will shed new light on our understanding of this GPCR's signaling and the regulation of neuronal functions by nonneuronal tissues.
Several of our observations suggest that the Exp step may be regulated by more than one signal. First, we noticed that activation of ChR2 in WT or aex mutant animals does not induce ectopic Exps. Only temporally correct light activation of AVL and DVB rescues the Exp defect of aex-2, aex-4, and aex-5. This observation indicates that activation of AVL and DVB (at least via ChR2) is permissive, but not completely instructive, to drive the Exp step of the DMP. Second, although constitutive activation of the G s ␣ pathway causes ectopic Exps in aex mutants, there is a strong tendency for Exps to occur at the proper time (Ϸ3 sec after pBoc). If aex genes were the sole connection between the intestinal pacemaker and activation of Exp, then one would expect to see a weaker tendency for Exps to occur at the proper time. These observations suggest that a second signal may function to regulate the Exp step. This signal could, for example, consist of a permissive signal that allows enteric muscles to be excited at the right time point in the DMP.
On first glance, one cannot help but notice the similarities between the intestinal aex genes and the neuronal secretory apparatus. SNARE proteins (AEX-4) are thought to create a membrane fusion structure at the nerve terminal, with SNARE regulators (AEX-1) playing a critical role in exocytosis (31) . Although the precise function of Rabs (AEX-6) in exocytosis, per se, is unclear, they play an important role in synaptic transmission (11) . Interestingly, although the regulator for AEX-6, AEX-3, has a similar defecation phenotype when mutated, the effector of AEX-6, RBF-1, does not (11) . Perhaps AEX-6, also known as Rab27, functions through a novel effector to regulate the DMP. Given the similarities between the genes involved in the DMP and those involved in synaptic transmission, the C. elegans intestine could be seen as an alternative means for investigating the mechanisms governing regulated exocytosis and, by analogy, synaptic transmission. When one adds on the observation that RNAi is highly ineffective in C. elegans neurons (32) but very effective in the intestine (17) , the intestine becomes an attractive model for discovering genes and genetic pathways regulating exocytosis.
Our work shows that the intestine may secrete a signal to activate the AVL and DVB neurons to induce the DMP (Fig.  S8 ). This might explain why the Ca 2ϩ oscillations are necessary for the timing of the DMP, because excitable cells use increased Ca 2ϩ to induce secretion. Our work provides the first explanation of how the intestine may regulate this behavior by activating the AVL and DVB neurons.
Materials and Methods
Refer to SI Text for detailed materials and methods and for a description of transgenes and clones.
Behavioral Assay. For detailed methods, refer to SI Text, section IX. Briefly, 8 -20 1-day-old adults were scored for 10 defecation cycles (i.e., 10 pBocs). Statistical significance was determined by using unpaired two-tailed Student t tests, with unequal variance.
ChR2 Experiments. For detailed methods, refer to SI Text, section X. Briefly, L4 larval-staged animals were grown in the presence or absence of 500 M all-trans retinal (Sigma) overnight at 22°C. The next day, defecation was scored on a Leica MZ16F fluorescent stereomicroscope with an x-Cite 120 excitation light source (EXFO) and a standard GFP filter. During the DMP, animals were stimulated with a brief Ϸ1-sec pulse of blue light, Ϸ2 sec after pBoc.
